Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-06

Clinical Trial Update: ECG Validation Study [Phase 2]

View source ↗

Summary

Phase 2 ECG validation study update for Analog Device in atrial fibrillation is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Analog Device

Snippet

Sponsor: Analog Device, Inc. | Conditions: Atrial Fibrillation | Phase 2 | Status: ACTIVE_NOT_RECRUITING